Main Menu

Clinical Pharmacodynamics Biomarker Group

Professor Banerji's team focuses on the development and validation of quantifiable and reproducible robust pharmacodynamic biomarkers in normal and tumour tissue that can be used in first-in-human studies.

Group leader

Professor Udai Banerji

Professor Udai Banerji

Professor Udai Banerji champions multidisciplinary working at the interface between early phase clinical trials, drug discovery and translational research related to drug resistance. He is Deputy Director of the Drug Development Unit at The ICR and Royal Marsden, and as a key member of the Centre for Cancer Drug Discovery, also heads the Clinical Pharmacodynamics Biomarker Group and the Clinical Pharmacology-Adaptive Therapy Group.

ORCID 0000-0003-1503-3123

Group members

Shaun Decordova

Higher Scientific Officer

Dr Olga Husson

Honorary Appointment

Dr Alvaro Ingles Russo

Honorary Appointment

Jason Malia

Higher Scientific Officer +44 20 3437 6554

Uma Ramachandra

Scientific Officer +44 20 3437 6961

​Dr Karen Swales

Senior Scientific Officer

Matthew Tall

Higher Scientific Officer